Investing in AOA is investing in the future of women's healthcare.
Our Vision and Mission
Our vision is to bring innovative, impactful and cost effective medical technologies from research and development into the hands of patients and providers.
Our mission is to bring to market the first accurate early stage non-invasive ovarian cancer diagnostic test that will improve clinical practice, help reduce patient mortality and deliver cost savings to payers.
The AOA team has worked in many diagnostic and medical device markets globally and demonstrated success through the understanding of each healthcare system.